Trials / Unknown
UnknownNCT03297814
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
A Randomized, Double Blind, Placebo Controlled Trial, Investigating the Effect of Intramuscular Injection of Allogenic Platelet Lysate for the Treatment of PAD
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Sophia Al-Adwan · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Allogenic platelet lysate will be injected in the gastrocnemius of patients with peripheral arterial disease (PAD)
Detailed description
Allogenic platelet rich plasma (PRP) will be collected from blood group AB donors. This plasma will be tested for the presence of any chronic infectious blood borne disease. Platelet lysate will be then prepared from the tested PRP to be intramuscularly injected in patients with PAD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet lysate | Intramuscular injection of platelet lysate |
| BIOLOGICAL | Placebo | intramuscular injection of normal saline |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2020-03-01
- Completion
- 2020-05-01
- First posted
- 2017-09-29
- Last updated
- 2019-07-24
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT03297814. Inclusion in this directory is not an endorsement.